Literature DB >> 24696083

The impact of bone mineral density testing, fracture assessment, and osteoporosis education in men treated by androgen deprivation for prostate cancer: a pilot study.

Michelle Nadler1, Shabbir Alibhai, Pamela Catton, Charles Catton, Jennifer Jones.   

Abstract

PURPOSE: Men receiving androgen deprivation therapy for prostate cancer have low knowledge of osteoporosis (OP) and engage in few healthy bone behaviors (HBBs). A multicomponent intervention was piloted in this population. Changes in OP knowledge, self-efficacy, health beliefs, and engagement in HBBs were evaluated.
METHODS: A pre-post pilot study was performed in a convenience sample of men recruited from the Princess Margaret Cancer Centre. Men were sent personalized letters explaining their dual x-ray absorptiometry (DXA) results and fracture risk assessment with an OP-related education booklet. Participants completed questionnaires assessing OP knowledge, self-efficacy, health beliefs, and current engagement in HBBs at baseline (T1) and 3 months post-intervention (T2). Paired t tests and McNemar's test were used to assess changes in outcomes.
RESULTS: A total of 148 men completed the study. There was an increase in OP knowledge (9.7 ± 4.3 to 11.4 ± 3.3, p < 0.0001) and feelings of susceptibility (16.5 ± 4.3 to 17.4 ± 4.7, p = 0.015), but a decrease in total self-efficacy (86.3 ± 22.9 to 81.0 ± 27.6, p = 0.007) from baseline to post-intervention. Men made appropriate changes in their overall daily calcium intake (p ≤ 0.001), and there was uptake of vitamin D supplementation from 44 % (n = 65) to 68 % (n = 99) (p < 0.0001). Men with bone loss (osteopenia or OP) had a greater change in susceptibility (1.9 ± 4.3 vs. -0.22 ± 4.2, p = 0.005) compared to men with normal bone density.
CONCLUSIONS: Our results provide preliminary evidence that a multicomponent intervention such as the one described can lead to increased knowledge and feelings of susceptibility regarding OP and can enhance uptake of some HBBs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696083     DOI: 10.1007/s00520-014-2183-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  60 in total

1.  Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women.

Authors:  C D Marci; W B Anderson; M B Viechnicki; S L Greenspan
Journal:  Calcif Tissue Int       Date:  2000-02       Impact factor: 4.333

2.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

3.  Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer.

Authors:  Kouta Ito; Elena B Elkin; Monica Girotra; Michael J Morris
Journal:  Ann Intern Med       Date:  2010-05-18       Impact factor: 25.391

4.  Introduction to the special series on motivational interviewing and psychotherapy.

Authors:  Hal Arkowitz; Henny A Westra
Journal:  J Clin Psychol       Date:  2009-11

5.  Social learning theory and the Health Belief Model.

Authors:  I M Rosenstock; V J Strecher; M H Becker
Journal:  Health Educ Q       Date:  1988

6.  Evaluation of osteoporosis risk assessment in veterans receiving androgen-deprivation therapy.

Authors:  Valerie D'Alesio; Brent E Salvig; T Neal Fourakre
Journal:  Consult Pharm       Date:  2011-01

7.  Theory-driven intervention improves calcium intake, osteoporosis knowledge, and self-efficacy in community-dwelling older Black adults.

Authors:  Oyinlola T Babatunde; Susan P Himburg; Frederick L Newman; Adriana Campa; Zisca Dixon
Journal:  J Nutr Educ Behav       Date:  2011-04-29       Impact factor: 3.045

8.  Development and validation of a food frequency questionnaire for assessing dietary calcium intake in the general population.

Authors:  Faidon Magkos; Yannis Manios; Eirini Babaroutsi; Labros S Sidossis
Journal:  Osteoporos Int       Date:  2004-09-10       Impact factor: 4.507

9.  Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.

Authors:  Abbas H Panju; Henriette Breunis; Angela M Cheung; Marc Leach; Neil Fleshner; Padraig Warde; Sarah Duff-Canning; Murray Krahn; Gary Naglie; Ian Tannock; George Tomlinson; Shabbir M H Alibhai
Journal:  BJU Int       Date:  2008-10-24       Impact factor: 5.588

Review 10.  Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.

Authors:  Philip J Saylor; Nancy L Keating; Matthew R Smith
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

View more
  6 in total

1.  Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.

Authors:  V T Nguyen; S W Edmonds; Y Lou; D W Roblin; K G Saag; P Cram; F D Wolinsky
Journal:  Osteoporos Int       Date:  2017-09-07       Impact factor: 4.507

2.  Osteoporosis-Related Health Behaviors in Men With Prostate Cancer and Survivors: Exploring Osteoporosis Knowledge, Health Beliefs, and Self-Efficacy.

Authors:  Annie-Claude M Lassemillante; Tina L Skinner; John D Hooper; John B Prins; Olivia R L Wright
Journal:  Am J Mens Health       Date:  2016-06-23

3.  Healthy Bones Study: can a prescription coupled with education improve bone health for patients receiving androgen deprivation therapy?-a before/after study.

Authors:  Derek S Tsang; Jennifer M Jones; Osai Samadi; Suhayb Shah; Nicholas Mitsakakis; Charles N Catton; William Jeon; Joshua To; Henriette Breunis; Shabbir M H Alibhai
Journal:  Support Care Cancer       Date:  2018-03-12       Impact factor: 3.603

4.  Bone health management in men undergoing ADT: examining enablers and barriers to care.

Authors:  A N Damji; K Bies; S M H Alibhai; J M Jones
Journal:  Osteoporos Int       Date:  2014-12-20       Impact factor: 4.507

5.  Implementing and Evaluating the Impact of BoneRx: A Healthy Bone Prescription for Men with Prostate Cancer Initiating Androgen Deprivation Therapy.

Authors:  Jennifer M Jones; Derek S Tsang; Shiyu Zheng; Ariel Yeheskel; Charles N Catton; Angela M Cheung; Robert Hamilton; Shabbir M H Alibhai
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

Review 6.  Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.

Authors:  Charlotte Beaudart; Mickael Hiligsmann; Nannan Li; E Michael Lewiecki; Stuart Silverman
Journal:  Osteoporos Int       Date:  2021-09-24       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.